throbber
Research Report
`
`High-Throughput Single Nucleotide
`Polymorphism Genotyping by Fluorescent
`5¢¢ Exonuclease Assay
`
`BioTechniques 27:538-552 (September 1999)
`
`Phillip A. Morin, Robert Saiz
`and Atousa Monjazeb
`Axys Pharmaceuticals,
`La Jolla, CA, USA
`
`ABSTRACT
`
`polymorphisms
`nucleotide
`Single
`(SNPs) are the class of DNA variants that
`are most common in the genome. Technolo-
`gies are needed that allow relatively high-
`throughput, high-quality genotyping of
`SNPs, with rapid assay development for in-
`dividual SNPs of interest. We have imple-
`mented an accurate and high-throughput
`SNP genotyping system using a commer-
`cially available fluorescent 5¢ exonuclease
`assay. Optimization of the assay system for
`low-volume reactions and low-probe con-
`centrations has reduced assay costs by
`75%. Using a simple assay optimization
`process, we successfully developed genotyp-
`ing assays for 92% of assays attempted
`(309 out of 335) and have generated over
`200 000 genotypes.
`
`538 BioTechniques
`
`INTRODUCTION
`
`Single nucleotide polymorphisms
`(SNPs) are the next frontier in genome-
`wide polymorphism screening for gene
`mapping, positional cloning and associ-
`ation studies (1,5,16), and the rush to
`obtain and screen SNPs has spawned
`both private and public research into
`new technology to meet those goals
`(10–12). These whole-genome screen-
`ing methods, however, are orders of
`magnitude beyond the needs of many
`research programs aimed at identifying
`and/or screening dozens or hundreds of
`SNPs in target populations. In addition,
`these methods might not allow the flex-
`ibility to rapidly and inexpensively
`implement a survey of a novel poly-
`morphism or to screen all of the poly-
`morphisms in a gene region.
`For these reasons, technologies are
`needed that allow relatively high-
`throughput, high-quality genotyping of
`SNPs, with rapid assay development,
`for individual SNPs of interest. Current
`popular methods include restriction
`fragment-length polymorphism analysis
`of polymerase chain reaction products
`(RFLP-PCR) (with gel electrophoresis
`for fragment detection), allele-specific
`oligonucleotide (ASO) hybridization
`(3,17,18), oligonucleotide ligation as-
`say (OLA) (2,20), “minisequencing”
`(14) and the 5¢ -exonuclease assay, or
`TaqMan(cid:212)
`(4,6,7,9). Cost, number of
`steps, complexity of reactions, preci-
`sion, accuracy, speed of completion and
`potential for automation are all impor-
`tant considerations for deciding which
`system will be used in particular set-
`tings, and Syvänen and Landegren (19)
`reviewed these factors for ASO, OLA
`
`and minisequencing in the context of
`several laboratory settings.
`We have evaluated and/or used all of
`the above methods, and we adopted the
`5¢ exonuclease assay as our system of
`choice for high-throughput SNP screen-
`ing. This assay takes advantage of the 5¢
`exonuclease activity of Taq DNA poly-
`merase to cause cleavage of allele-spe-
`cific probes, which are hybridized to
`template DNA during PCRs. The
`probes are double-labeled with reporter
`(FAM or TET) and quencher (TAMRA)
`dyes at the 5¢ and 3¢ ends, respectively,
`and cleavage of the probes causes in-
`crease in the fluorescence of the re-
`porter dyes in solution. Differential hy-
`bridization of the two allele-specific
`probes results in cleavage of the probes
`only if they are perfectly annealed to
`their respective allele templates, result-
`ing in increase of fluorescence of one or
`both reporter fluors that can be plotted
`and segregated to determine the tem-
`plate genotype. The advantages of this
`assay over ASO and OLA include (i)
`single-tube amplification and detection,
`(ii) fluorescence signal proportional to
`PCR product amplification, (iii) lower
`reagent and labor costs per genotype,
`(iv)genotype assignment based on
`clearly separated clusters of fluorescent
`values and (v) simple, automatable as-
`say implementation procedures. We
`used the LS-50B fluorescent spectrom-
`eter with a plate reader and the ABI
`PRISM(cid:210) 7700 Sequence Detector (both
`from PE Biosystems, Foster City, CA,
`USA) for data acquisition and analysis
`(see Discussion).
`This manuscript outlines our meth-
`ods and modifications to the protocols
`for the 5¢ exonuclease assay system,
`
`Vol. 27, No. 3 (1999)
`
`1 OF 9
`
`THERMO FISHER EX. 1037
`
`

`
`Research Report
`
`current and potential throughput in our
`laboratory and automation systems for
`increasing efficiency. These modifica-
`tions and the supporting data were gen-
`erated over 3 years of assay develop-
`ment and genotyping, so different
`experiments were conducted with dif-
`ferent assays and sample subsets.
`
`MATERIALS AND METHODS
`
`Primer and Probe Design
`
`Oligonucleotide PCR primers and
`double dye-labeled probes were de-
`signed using Primer Express(cid:212)
`(Version
`1 for Macintosh(cid:210) Power PC; PE Biosys-
`tems), and assay design and conditions
`are primarily based on the allelic dis-
`crimination protocol from PE Biosys-
`tems (8). Default conditions in the pro-
`gram were used for reaction conditions,
`and the following parameters were set
`before selecting primers: primer con-
`centration = 250 nM; primer melting
`temperature (Tm) range = 58(cid:176) –60(cid:176) C;
`primer optimal Tm = 59(cid:176) C; maximum
`primer Tm difference = 2(cid:176) C; probe does
`not have a 5¢ ‘G’; probe Tm must be 7(cid:176)
`greater than primer Tm. Other parame-
`ters were changed if necessary to allow
`the program to select primers near the
`probe. The OLIGO 5.0 program (Na-
`tional Biosciences, Plymouth, MN,
`USA) has also been used effectively.
`Using the default conditions, probe se-
`quences were designed to have Tms of
`76(cid:176) C, and primers were designed for a
`Tm of 69(cid:176) C. Empirically, optimized an-
`nealing temperatures (Ta) for assays de-
`signed with either program were found
`to be approximately 60(cid:176) – 62(cid:176) C in the
`PCR conditions outlined below.
`Probes were selected in Primer Ex-
`press to obtain a theoretical Tm of 67(cid:176) –
`1(cid:176) C, with the polymorphic site as close
`to the center of the oligonucleotide as
`possible to provide the greatest differ-
`ence in Tm between perfectly matched
`probe and template and the mismatch.
`Slight changes in probe length were
`made to keep the Tm constant for the
`two allele-specific probes (e.g., a probe
`with an ‘A’ might be 1–3 nucleotides
`[nt] longer than the alternate allele
`probe containing a ‘G’ at the polymor-
`phic site). This design should allow per-
`fectly matched probes to hybridize
`
`540 BioTechniques
`
`strongly to the template DNA before the
`PCR primers anneal and to be cleaved
`rather than displaced by the Taq DNA
`polymerase during the extension phase.
`Mismatched probe/template pairs will
`be unstable at the PCR cycling condi-
`tions, and thus will not be cleaved.
`Once probe sequences were select-
`ed, all possible PCR primer pairs were
`determined automatically by Primer
`Express, and a pair was selected based
`on the optimal criteria of the program
`(as indicated by the Penalty score),
`product length (£ 150 bp) and by having
`the forward primer close (£ 30 bp if pos-
`sible) to the 5¢ end of the probe. The
`distance between the forward primer
`and the probe (which both anneal to the
`same strand of the template DNA) is
`important if they are further than ap-
`proximately 150 bp apart. We have
`found that signal intensity often falls off
`substantially if the forward primer is
`more than 100 bp from the probe bind-
`ing site (data not shown). The two alter-
`nate allele probes were synthesized
`with the reporter dyes FAM and TET,
`respectively, on the 5¢ nucleotides, and
`with TAMRA and a blocking phosphate
`on the 3¢ nucleotide, and then HPLC-
`purified. Primer oligonucleotides were
`unmodified and unpurified. For some
`AT-rich sequences, probe sequences
`can be over 40 nt. Such long probes
`tend to have higher background fluores-
`cence, but some work well regardless.
`All probes were synthesized by PE
`Biosystems or Integrated DNA Tech-
`nologies (IDT; Coralville, IA, USA).
`PCR primers were synthesized by Oper-
`on Technologies (Alameda, CA, USA).
`
`PCR Annealing Temperature
`Optimization
`
`A test for PCR product amplification
`was conducted for each primer pair to
`determine the optimal amplification
`temperature. Replicate PCRs were per-
`formed on a single DNA sample (20 ng
`of DNA dried into wells of 96-well PCR
`plates) at 58(cid:176) , 60(cid:176) and 62(cid:176) C using 200
`nM final primer concentration, in 1·
`TaqMan PCR Master Mix (PE Biosys-
`tems), without assay probes. The PCR
`products were electrophoresed through
`2% agarose gel in the presence of ethid-
`ium bromide and visualized by fluores-
`cence in UV light, and the Ta that pro-
`
`duced the highest product yield was se-
`lected for all future amplifications.
`
`Fluorescence Optimization
`
`Fluorescence signal intensity was
`optimized by testing an array of primer
`concentrations [forward:reverse (nM):
`300:50, 300:300, 300:900, 900:50,
`900:300 and 900:900] using standard
`assay conditions (below). This subset
`of concentration pairs for the two
`primers was derived empirically to re-
`duce the number of reactions that need
`to be run for each assay optimization.
`The PCR products, amplified in tripli-
`cate (with both probes present) for each
`set of concentrations, were analyzed in
`the ABI PRISM 7700 Sequence Detector
`for the change in the fluorescence of
`one or both of the reporter dyes relative
`to the quencher dye (D RQ), and the
`concentrations that produced the maxi-
`mum D RQ were selected for the assay.
`
`Assay Conditions
`Genomic DNA (5 m L of 4 ng/m L
`DNA in low EDTA TE [10 mM Tris,
`0.1 mM EDTA, pH 8.0]) for each sam-
`ple was aliquoted into 96-well PCR
`plates (Robbins Scientific [Sunnyvale,
`CA, USA] or Corning Costar [Cam-
`bridge, MA, USA]) dried at 80(cid:176) C for
`about 30 min and stored at ambient con-
`ditions until used. PCR cocktails includ-
`ing both probes (100 nM each) were set
`up using the derived primer concentra-
`tions and 1· TaqMan(cid:212)
`PCR Master
`Mix for the 7700, or Buffer II (100 mM
`Tris, pH 8.0, 500 mM KCl, 1% gelatin),
`with 7.5 mM magnesium chloride, the
`dNTPs (dA, G, C, U; 1:1:1:2 ratio), 0.05
`U/m L AmpliTaq Gold(cid:212)
`(PE Biosys-
`tems) and 0.01 U/m L Uraci-DNA-Gly-
`cosylase for the LS-50B. Five, ten or
`twenty microliters of the PCR cocktail
`were added to each well of the 96-well
`plate, and the plates were sealed with ei-
`ther caps or transparent plastic sealers
`(Seal-PLT-100; Elkay Products, Shrews-
`bury, MA, USA). PCR amplification
`was achieved under the following cy-
`cling conditions: 2 min at 50(cid:176) C, 10 min
`at 95(cid:176) C, then 40 cycles of 94(cid:176) C for 30 s,
`60(cid:176) C (or empirically derived optimal
`Tm) for 30 s. After cycling, samples re-
`mained at 4(cid:176) C until removal from the
`PCR thermal cyclers for analysis.
`
`Vol. 27, No. 3 (1999)
`
`2 OF 9
`
`THERMO FISHER EX. 1037
`
`

`
`Research Report
`
`542 BioTechniques
`
`Data Acquisition and Analysis
`
`Before we acquired the ABI PRISM
`7700 Sequence Detector, we used the
`LS-50B Fluorometer with plate reader
`for data acquisition and analysis on 256
`of the assays summarized in this report.
`Excel(cid:210) macros for data analysis were
`written by Jeff Marmaro (PE Biosys-
`tems) (9) and modified by P.A.M. This
`software uses a set of control genotypes
`as references to call alleles. The assays
`were done in 20-m L reaction volumes,
`diluted to 50 m L with deionized water
`and transferred to reflective white
`plates for fluorescence detection.
`For 79 assays, analyzed on the ABI
`PRISM 7700 Sequence Detector, plates
`were placed into the sequencer and ana-
`lyzed for post-PCR allelic discrimina-
`tion without normalization. The dye
`component data for each well are dis-
`played graphically and in a table, and
`alleles can be assigned directly from the
`graphical display using a selection func-
`tion in the software and a drag-down
`menu of genotype options, then export-
`ed for spreadsheet or database storage.
`
`RESULTS
`
`Number of Assays
`To date, we have designed 5¢ exonu-
`clease assays for over 330 SNPs, and
`we typically genotype between 300 and
`3000 individuals per assay. We use pub-
`licly available polymorphisms (Table 1)
`and novel SNPs derived from rese-
`quencing projects to design new assays
`following simple rules outlined by PE
`Biosystems (8).
`
`Assay Conditions
`
`Maximizing the fluorescence signal
`created by cleavage of the dual-labeled
`probes is critical, especially when using
`the ABI PRISM 7700, as it is less sensi-
`tive than the LS-50B Fluorometer and
`other fluorometers. Optimal tempera-
`ture and primer concentrations for the
`PCRs are determined using (i) multiple
`temperatures to find the highest tem-
`perature at which we obtain high PCR
`product yield (detected by agarose gel
`electrophoresis), and (ii) primer con-
`centration matrices for PCRs in the
`
`Vol. 27, No. 3 (1999)
`
`3 OF 9
`
`THERMO FISHER EX. 1037
`
`

`
`Research Report
`
`presence of the fluorescent probes to
`determine the primer concentrations
`that result in the greatest fluorescent
`signal of one or both of the probes from
`one DNA sample. Assays are designed
`to use a PCR primer Ta of approximate-
`ly 60(cid:176) C, and 95% (75 out of 79) of as-
`says optimized for the ABI PRISM 7700
`have optimal Tas between 58(cid:176)
`and
`62(cid:176) C. We have tried several primer
`concentration matrices, and find that
`96% (51 out of 53) of assays have opti-
`mal concentrations falling within a
`300· 900 nM matrix (forward:reverse
`primer concentration: 300:300, 15%;
`300:900, 25%; 900:300, 17%; and 900:
`900, 40%). The differences between as-
`says amplified with the empirically
`derived optimal PCR primer concen-
`trations and alternative concentrations
`are primarily in the signal intensity of
`one or the other fluorescent dye, which
`will tend to skew the heterozygote
`genotype cluster toward one or the oth-
`er homozygote cluster.
`
`PCR Cocktail Reagents
`
`The 7700 ABI PRISM is less sensi-
`tive than the LS-50B Fluorometer and
`uses different software for fluorescent
`dye spectral analysis, so signal intensi-
`ty is more important when using the
`Model 7700. Initial assays were per-
`formed using PE Biosystem’s Buffer II
`(see Materials and Methods) with 7.5
`mM magnesium chloride; however, the
`manufacturer now markets a propri-
`etary 2· buffer mixture that includes a
`passive dye (ROX) as an internal stan-
`dard, produces high signal intensity for
`most assays and includes the dNTPs,
`AmpliTaq Gold and Uracil-DNA-Gly-
`cosylase in the mixture. Thus, only
`probes, primers, DNA and water need
`to be added for each reaction. This is
`convenient and increases quality con-
`trol in assay preparation. We have fur-
`ther increased efficiency and consisten-
`cy among samples by diluting all
`samples to 4 ng/m L, aliquoting 20 ng of
`DNA into replicate PCR plates using a
`96-syringe pipettor (Robbins Scientif-
`ic) and drying the replicate plates. This
`allows us to add the PCR cocktail (also
`using the 96-syringe pipettor) to plates
`with the DNA already in place, pre-
`venting sample mix-up and reducing
`variation in pipettor volume.
`
`544 BioTechniques
`
`Reaction Volume
`
`To date, we performed about 200 of
`our assays in 20-m L volumes, instead of
`50 m L as suggested by PE Biosystems,
`as initial tests indicated no loss of geno-
`type quantities or quality (data not
`shown). To quantify the success rate us-
`ing 20-m L reactions, we surveyed all 46
`assays genotyped during the 7-month
`period just before we switched to 10-m L
`reactions. From those assays, there were
`53 165 genotypes generated from 639
`plates, with an overall scorable geno-
`type rate of 93.7% (standard deviation
`[SD]: 0.07%/plate or £ 6.6 genotypes
`depending on how many samples were
`on the plate). We have recently shown
`that 10- and 5-m L volumes can be used
`in the same 96-well plates without sig-
`nificant loss of fluorescence or allelic
`discrimination (Figure 1A). For 40 as-
`says performed with 5- or 10-m L vol-
`umes, we have achieved a mean of
`94.3% scorable genotypes per 96-well
`plate (339 plates genotyped). This fur-
`ther indicates that reaction volume
`down to 5 m L does not affect the scora-
`bility of the data, but we must caution
`that in some thermal cyclers, the small
`volume reactions fail more frequently.
`The PCRs for these assays have been
`performed in 96-well plates (from Rob-
`bins Scientific or Corning Costar) in a
`PTC-100(cid:212)
`Thermal Cycler (MJ Re-
`search, Watertown, MA, USA) and
`with GeneAmp(cid:210) PCR Systems 9600
`and 9700 with thermal lids (both from
`PE Biosystems). We evaluated the use
`of mineral oil overlays for small volume
`(5 m L) PCR, but found that it was not
`necessary for amplification, and it re-
`duced the fluorescent signal detected by
`the ABI PRISM 7700 (data not shown).
`
`Signal Strength and Allelic
`Discrimination
`
`PCRs were optimized (see Materials
`and Methods) to produce the maximum
`signal-to-noise ratio. Probe concentra-
`tion affects overall signal intensity and,
`to a much lesser extent, allelic discrimi-
`nation. The suggested probe concentra-
`tion is 200 nM, but we have found that
`little resolution is lost by using 100 nM
`of each probe, and twice as many reac-
`tions can be performed (Figure 1B).
`Where optimal conditions cannot be
`
`found using these initial steps, signal
`strength and allelic discrimination can
`sometimes be increased by increasing
`primer concentrations, addition of PCR
`cycles and/or longer annealing times
`(e.g., 60 s vs. 30 s) (data not shown).
`
`Assay Reproducibility and Accuracy
`
`To test the reproducibility of the as-
`says, we selected five assays and geno-
`typed four plates in duplicate using 10-
`m L volumes (on separate days with new
`PCR cocktail prepared each time). Out
`of 3760 genotypes total, there was one
`inconsistent genotype call. Forty-four
`genotypes (1.2%) were called “null” be-
`cause they either failed to amplify in one
`replicate or were not given a genotype
`designation because they were question-
`able (i.e., fell outside of the expected
`clusters of points). The overall success
`rate (percent accurately called geno-
`types) per assay ranged from 98.1% to
`99.6%. Figure 2 shows a single dupli-
`cate set of plates for each assay.
`To estimate the accuracy of the as-
`says, we examined the Mendelian inher-
`itance for 26 assays genotyped on a sin-
`gle 10-generational pedigree of 555
`individuals from the island of Tristan de
`Cunha, from which we have sampled
`265 individuals who were living on the
`island in 1997. This pedigree is extreme-
`ly well studied, so we are confident that
`there are no incorrect relationships. We
`found seven genotypes, (0.1%) out of
`6653, that were not compatible with
`Mendelian inheritance in this pedigree.
`
`Failed Assays
`
`Assay quality is dependent on ampli-
`fication of the product and appropriate
`annealing and cleavage of the probes in
`the PCR. Although primer picking pro-
`grams help to select primers and probes
`that have optimal base composition, Tas
`and lack of secondary structure, they are
`not perfect, especially given the high
`magnesium concentrations and other
`assay reagents that affect the PCR. We
`have found that in the majority of cases,
`our assays work with no additional opti-
`mization beyond the initial temperature
`and primer concentration matrices (see
`Materials and Methods). The most fre-
`quent reason for failure is lack of prod-
`uct amplification, which can be over-
`
`Vol. 27, No. 3 (1999)
`
`4 OF 9
`
`THERMO FISHER EX. 1037
`
`

`
`Research Report
`
`546 BioTechniques
`
`Vol. 27, No. 3 (1999)
`
`5 OF 9
`
`THERMO FISHER EX. 1037
`
`

`
`Research Report
`
`come by additional changes to the PCR
`conditions (e.g., lower annealing tem-
`perature, higher primer concentration,
`etc.) or by redesigning the PCR primers.
`In a few cases in which assays have not
`
`been resurrected by primer redesign, the
`most frequent putative cause (3 assays
`out of 4 analyzed) has been long probe
`sequences (>40 nt) designed in A/T-rich
`DNA regions.
`
`Figure 1. (A) Results from two assays completed on the same 94 DNA samples, using 5-, 10-, and 20-m L
`PCR volumes. Graph scales have been held constant between different volumes for each assay. The three
`clusters of points in each graph represent the allele 1 homozygotes (lower right), heterozygotes (middle),
`allele 2 homozygotes (upper left) and low or no-amplification samples and controls (lower left). Each
`plate contains one pooled DNA sample, which often falls between the cluster of heterozygote data points
`and the most common allele data points. (B) Typical results for probe concentrations of 100 and 200 nM
`(volume = 20 m L). The graph scales have been changed to show that relative distribution of points re-
`mains constant even though the overall fluorescent intensity changes with probe concentration.
`
`548 BioTechniques
`
`DISCUSSION
`
`The data quality of this assay sys-
`tem, along with the 1-tube assay that
`requires no post-PCR processing,
`makes the 5¢ exonuclease assay very at-
`tractive for high-throughput genotyp-
`ing. ASO hybridization systems with
`high-density arrays can produce higher
`throughput; however, signal and back-
`ground variation among samples and
`assays have caused a higher rate of
`genotype ambiguity and miscalls for us
`in the past. Our system of checking for
`Mendelian inheritance problems in ex-
`tended pedigrees has shown that we
`rarely have any incorrect genotypes
`from 5¢ exonuclease assays.
`We have addressed two of the prima-
`ry limitations of this system: (i) the high
`cost of reagents and (ii) the ability to au-
`tomate PCR setup and amplification
`through reduction of reaction volumes.
`We have designed over 340 systems for
`the 5¢ exonuclease assay and completed
`genotyping of 300–3000 DNA samples
`for most of them (>200000 genotypes).
`To date, using the methods described
`here, over 95% of the assays have been
`optimized, and they produced high-
`quality genotype data, most of which
`has been verified by checks for Men-
`delian inheritance in extended pedi-
`grees. Our primary modifications of PE
`Biosystems protocols for these assays
`have included drying DNA into plates,
`PCR product optimization and an ab-
`breviated primer concentration opti-
`mization step, and reduced volume
`PCRs. Our optimization procedure re-
`quires 33 PCRs (when done in tripli-
`cate) and nine agarose gel lanes per as-
`say. This is a reduction of 33 PCRs and
`gel lanes from the optimization protocol
`recommended by PE Biosystems for al-
`lelic discrimination (15), which requires
`64 PCRs (but does not suggest checking
`products on agarose gels).
`The cost per reaction is approxi-
`mately $0.42 for the 10-m L reaction
`volume (including all consumable ma-
`terials), assuming full use of the probes
`(about 10 000 reactions). The 2· PCR
`mixture from PE Biosystems costs
`$0.34/reaction, and the probe costs vary
`by manufacturer, but can generally be
`purchased for about $400 each or $800
`for an assay with enough probe to per-
`form at least 10 000 10-m L reactions.
`
`Vol. 27, No. 3 (1999)
`
`6 OF 9
`
`THERMO FISHER EX. 1037
`
`

`
`Research Report
`
`Figure 2. Results from five assays completed in duplicate, 10-mm L reaction volumes. Five 96-well plates were genotyped in duplicate for each assay for esti-
`mates of reproducibility, and one representative set of duplicate plates is shown for each assay. The Cyp1A1 SNP assay detected no homozygotes for the rare al-
`lele for the plate shown here. The two clusters are for the common homozygotes and the more rare heterozyotes.
`
`550 BioTechniques
`
`Vol. 27, No. 3 (1999)
`
`7 OF 9
`
`THERMO FISHER EX. 1037
`
`

`
`These costs can be decreased by using
`a homemade buffer mixture instead of
`the 2· Master Mix (PE Biosystems) or
`by developing even smaller volume
`PCR amplification and fluorescence
`detection methods.
`The primary bottlenecks in this pro-
`duction line are primer and probe syn-
`thesis (typically 3 days for primers, 5–7
`days for probes), optimization steps and
`availability of thermal cyclers needed to
`amplify 5000–10 000 samples.
`The time needed for primer and
`probe synthesis has been decreased by
`changes in probe synthesis techniques
`that have eliminated post-synthesis
`HPLC purification, addition of TAM-
`RA to each probe and a second HPLC
`purification (13).
`Optimization steps have been imple-
`mented to maximize the chances that an
`assay will work reliably when applied
`across hundreds or thousands of sam-
`ples. The possible permutations in each
`
`optimization, however, have been grad-
`ually reduced after optimization of
`dozens of assays to minimize the
`reagents, labor and time involved. We
`originally tested five annealing temper-
`atures for each assay (56(cid:176) , 58(cid:176) , 60(cid:176) , 62(cid:176)
`and 64(cid:176) C), a matrix of nine probe
`concentrations (100, 500 and 900 nM),
`and a matrix of nine primer concentra-
`tions (50, 300 and 900 nM) for assay
`optimization. We have empirically de-
`rived a subset of optimization steps and
`dropped the probe concentration matrix
`altogether, for a smaller set of steps
`which yields robust results for 95% of
`our assays (see Materials and Methods).
`Volume reduction presents several
`cost-saving and labor-saving benefits.
`First, the PCR components (2· Master
`Mix), including enzymes and passive
`dye standard (ROX), which make up ap-
`proximately 80% of the disposable ma-
`terials costs (excluding probes) with 20-
`m L reactions, are reduced to 66% of
`
`disposable materials costs with 10-m L
`reactions. Second, probe synthesis is a
`fixed cost that is about $0.16/reaction
`when £ 5000 genotypes are processed at
`the 20-m L volume, but reducing volume
`to 10 m L obviously allows double the
`number of genotypes for the same cost
`—a 50% reduction in the per genotype
`cost. Third, mixing and aliquoting of
`smaller volumes is more easily automat-
`ed for robotic workstations, thereby re-
`ducing labor and potential for human er-
`ror. Finally, small volumes can be cycled
`more efficiently in the thermal cyclers,
`so more plates can be cycled through
`each machine in a day, and automatic
`transfer of plates into and out of a PCR
`thermal cycler is ultimately achievable
`for amplifying large numbers of plates
`without the need for a person to feed the
`plates into multiple PCR machines.
`Hardware and software for analysis
`of 5¢ exonuclease assay results are cur-
`rently available with the ABI PRISM
`
`8 OF 9
`
`THERMO FISHER EX. 1037
`
`

`
`Research Report
`
`7700 Sequence Detector. This system
`provides software for rapid analysis of
`the data. An alternative to this special-
`ized and expensive instruments is a
`simple fluorometer with the ability to
`detect multiple fluorescent emission
`wavelengths in the 500–600-nm range.
`Excel macros, developed by PE
`Biosystems (9) and modified by us, can
`be used to organize the fluorescent
`emission data, to separate alleles based
`on controls by multicomponent analy-
`sis of the wavelengths and to automate
`genotype calls. This system (using the
`LS-50B Fluorometer with plate reader)
`has worked well for us; however, it re-
`quires transfer of samples from PCR
`plates to reading plates, assumptions
`and cut-offs for allele calling and man-
`ual checking of genotypes to be sure
`that the allele calling was accurate. As
`most fluorometers are more sensitive
`than the ABI PRISM instruments, assays
`developed for fluorometers do not need
`
`to be optimized as much as the assays
`we have described here. The benefit of
`the fluorometer-based system is that it
`can make use of equipment and soft-
`ware presently available in many labo-
`ratories, but at the expense of precise
`and user-friendly hardware and soft-
`ware that allow high throughput in
`analysis and quality control.
`The 5¢ exonuclease assay system in-
`corporates (i) ease of assay design, (ii)
`commercial availability of oligonu-
`cleotide probes, instruments and analy-
`sis software and (iii) scalability for labo-
`ratories producing <100 genotypes to
`those producing ten-thousand genotypes
`per week. Although this system is un-
`likely to meet the needs of genome-wide
`SNP screening as proposed by several
`authors (1,5,15), for population-level
`genotyping of specific polymorphisms,
`candidate genes and disease genes, this
`system offers ease of use, throughput
`and accuracy not previously available.
`
`ACKNOWLEDGMENTS
`
`We thank Shelley Webster at Axys
`and Gianfranco DeFeo and Chris Grim-
`ley of PE Biosystems for technical
`help. We also thank Chris Hinckel for
`discussion and advice and Andy Wat-
`son, Penny Isabella and several anony-
`mous reviewers for useful suggestions.
`
`REFERENCES
`
`1.Collins, F.S., M.S. Guyer and A.
`Chakravarti. 1997. Variations on a theme:
`cataloging human DNA sequence variation.
`Science 278:1580-1581.
`2.Delahunty, C., W. Ankener, Q. Deng, J. Eng
`and D.A. Nickerson. 1996. Testing the feasi-
`bility of DNA typing for human identification
`by PCR and an oligonucleotide ligation assay.
`Am. J. Hum. Genet. 58:1239-1246.
`3.Handelin, B. and A.P. Shuber. 1996. Simul-
`taneous detection of multiple point mutations
`using allele-specific oligonucleotides, p.
`9.4.1-9.4.5. In N.C. Dracopoli, J.L. Haines,
`B.R. Korf, D.T. Moir, C.C. Morton, C.E. Seid-
`man, J.G. Seidman and D.R. Smith (Eds.),
`Current Protocols in Human Genetics. John
`Wiley & Sons, New York.
`4.Holland, P.M., R.D. Abramson, R. Watson
`and D.H. Gelfand. 1991. Detection of specif-
`ic polymerase chain reaction product by utiliz-
`ing the 5¢ to 3¢ exonuclease activity of Ther-
`mus aquaticus DNA polymerase. Proc. Natl.
`Acad. Sci. USA 88:7276-7280.
`5.Lander, E.S. 1996. The new genomics: global
`views of biology. Science 274:536-539.
`
`6.Lee, L.G., C.R. Connell and W. Bloch. 1993.
`Allelic discrimination by nick-translation
`PCR with fluorogenic probes. Nucleic Acids
`Res. 21:3761-3766.
`7.Livak, K., S.J.A. Flood, J. Marmaro, W.
`Giusti and K. Deetz. 1995. Oligonucleotides
`with fluorescent dyes at opposite ends provide
`a quenched probe system useful for detecting
`PCR product and nucleic acid hybridization.
`PCR Methods Appl. 4:357-362.
`8.Livak, K., J. Marmaro and S. Flood. 1995.
`Guidelines for designing TaqMan(cid:212)
`fluoro-
`genic probes for 5¢ nuclease assay. PE Applied
`Biosystems, Foster City, CA.
`9.Livak, K.J., J. Marmaro and J.A. Todd.
`1995. Towards fully automated genome-wide
`polymorphism screening. Nat. Genet. 9:341-
`342.
`10.Marshall, E. 1997. ‘Playing chicken’ over
`gene markers. Science 278:2046-2048.
`11.Marshall, E. 1997. Snipping away at genome
`patenting. Science 277:1752-1753.
`12.Marshall, E. 1997. The hunting of the SNP.
`Science 278:2047.
`13.Mullah, B., K. Livak, A. Andrus and P.
`Kenney. 1998. Efficient synthesis of double
`dye-labeled oligodeoxyribonucleotide probes
`and their application in a real time PCR assay.
`Nucleic Acids Res. 26:1026-1031.
`14.Pastinen, T., A. Kurg, A. Metspalu, L. Pel-
`tonen and A.-C. Syvänen. 1997. Minise-
`quencing: a specific tool for DNA analysis
`and diagnostics on oligonucleotide arrays.
`Genome Res. 7:606-614.
`15.PE Biosystems. TaqMan(cid:210) Allelic Discrimi-
`nation Demonstration Kit Protocol. Part No.
`4303267. Foster City, CA.
`16.Risch, N. and K. Merikangas. 1996. The fu-
`ture of genetic studies of complex human dis-
`eases. Science 273:1516-1517.
`17.Shuber, A.P., L.A. Michalowsky, G.S. Nass,
`J. Skoletsky, L.M. Hire, S.K. Kotsopoulos,
`M.F. Phipps, D.M. Barberio and K.W.
`Klinger. 1997. High throughput parallel
`analysis of hundreds of patient samples for
`more than 100 mutations in multiple disease
`genes. Hum. Mol. Genet. 6:337-347.
`18.Shuber, A.P., J. Skoletsky, R. Stern and
`B.L. Handelin. 1993. Efficient 12-mutation
`testing in the CFTR gene: a general model for
`complex mutation analysis. Hum. Mol. Genet.
`2:153-158.
`19.Syvänen, A.-C. and U. Landegren. 1994.
`Detection of point mutations by solid-phase
`methods. Hum. Mutat. 3:172-179.
`20.Tobe, V.O., S.L. Taylor and D.A. Nickerson.
`1996. Single-well genotyping of diallelic se-
`quence variations by a two-color ELISA-
`based oligonucleotide ligation assay. Nucleic
`Acids Res. 24:3728-3732.
`
`Received 24 March 1999; accepted 21
`May 1999.
`
`Address correspondence to:
`Dr. Phillip A. Morin
`Axys Pharmaceuticals, Inc.
`11099 North Torrey Pines Road, Suite 160
`La Jolla, CA 92037, USA
`Internet: morin@axyspharm.com
`
`Vol. 27, No. 3 (1999)
`
`9 OF 9
`
`THERMO FISHER EX. 1037

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket